ReviewViruses2023

Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA.

An-Qi Zhuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.